According to SP Tulsian of sptulsian.com, Lupin may touch Rs 885-890. “The company received the USFDA approval for launch of the generic version of the Sanofi‘s Ambien, which is for curing of insomnia and it has USD 400 million markets,†he adds.
first published: Sep 17, 2013 12:05 pm
A collection of the most-viewed Moneycontrol videos.

Market Braces For Tough Session Amid AI-Led Global Tech Rout | RBI Policy Today | Opening Bell Live

Live: Nifty slips below 25,650 amid broad-based selloff; IT continues freefall | Closing Bell

Can Nifty Power Ahead For Fourth Day Despite Anthropic-Led Tech Jitters? | Opening Bell Live

Investing for a new era | LIVE conversation with Mukesh Ambani & Larry Fink
You are already a Moneycontrol Pro user.